These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 11072076)

  • 21. SF2/ASF binds to a splicing enhancer in the third HIV-1 tat exon and stimulates U2AF binding independently of the RS domain.
    Tange TØ; Kjems J
    J Mol Biol; 2001 Sep; 312(4):649-62. PubMed ID: 11575921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pre-mRNA splicing in the absence of an SR protein RS domain.
    Zhu J; Krainer AR
    Genes Dev; 2000 Dec; 14(24):3166-78. PubMed ID: 11124808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alternative splicing of the adenylyl cyclase stimulatory G-protein G alpha(s) is regulated by SF2/ASF and heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) and involves the use of an unusual TG 3'-splice Site.
    Pollard AJ; Krainer AR; Robson SC; Europe-Finner GN
    J Biol Chem; 2002 May; 277(18):15241-51. PubMed ID: 11825891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exonic splicing enhancer-dependent selection of the bovine papillomavirus type 1 nucleotide 3225 3' splice site can be rescued in a cell lacking splicing factor ASF/SF2 through activation of the phosphatidylinositol 3-kinase/Akt pathway.
    Liu X; Mayeda A; Tao M; Zheng ZM
    J Virol; 2003 Feb; 77(3):2105-15. PubMed ID: 12525645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SR proteins Asf/SF2 and 9G8 interact to activate enhancer-dependent intron D splicing of bovine growth hormone pre-mRNA in vitro.
    Li X; Shambaugh ME; Rottman FM; Bokar JA
    RNA; 2000 Dec; 6(12):1847-58. PubMed ID: 11142383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Splicing of phenylalanine hydroxylase (PAH) exon 11 is vulnerable: molecular pathology of mutations in PAH exon 11.
    Heintz C; Dobrowolski SF; Andersen HS; Demirkol M; Blau N; Andresen BS
    Mol Genet Metab; 2012 Aug; 106(4):403-11. PubMed ID: 22698810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization and cloning of the human splicing factor 9G8: a novel 35 kDa factor of the serine/arginine protein family.
    Cavaloc Y; Popielarz M; Fuchs JP; Gattoni R; Stévenin J
    EMBO J; 1994 Jun; 13(11):2639-49. PubMed ID: 8013463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HnRNP A1/A2 and SF2/ASF regulate alternative splicing of interferon regulatory factor-3 and affect immunomodulatory functions in human non-small cell lung cancer cells.
    Guo R; Li Y; Ning J; Sun D; Lin L; Liu X
    PLoS One; 2013; 8(4):e62729. PubMed ID: 23658645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selection and characterization of pre-mRNA splicing enhancers: identification of novel SR protein-specific enhancer sequences.
    Schaal TD; Maniatis T
    Mol Cell Biol; 1999 Mar; 19(3):1705-19. PubMed ID: 10022858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mapping the SF2/ASF binding sites in the bovine growth hormone exonic splicing enhancer.
    Dirksen WP; Li X; Mayeda A; Krainer AR; Rottman FM
    J Biol Chem; 2000 Sep; 275(37):29170-7. PubMed ID: 10880506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific interactions between proteins implicated in splice site selection and regulated alternative splicing.
    Wu JY; Maniatis T
    Cell; 1993 Dec; 75(6):1061-70. PubMed ID: 8261509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel exploitation of a nuclear function by influenza virus: the cellular SF2/ASF splicing factor controls the amount of the essential viral M2 ion channel protein in infected cells.
    Shih SR; Krug RM
    EMBO J; 1996 Oct; 15(19):5415-27. PubMed ID: 8895585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth hormone deficiency and splicing fidelity: two serine/arginine-rich proteins, ASF/SF2 and SC35, act antagonistically.
    Solis AS; Peng R; Crawford JB; Phillips JA; Patton JG
    J Biol Chem; 2008 Aug; 283(35):23619-26. PubMed ID: 18586677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The human splicing factors ASF/SF2 and SC35 possess distinct, functionally significant RNA binding specificities.
    Tacke R; Manley JL
    EMBO J; 1995 Jul; 14(14):3540-51. PubMed ID: 7543047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors involved in the activation of pre-mRNA splicing from downstream splicing enhancers.
    Achsel T; Shimura Y
    J Biochem; 1996 Jul; 120(1):53-60. PubMed ID: 8864844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of SR protein modular domains in alternative splicing specificity in vivo.
    van Der Houven Van Oordt W; Newton K; Screaton GR; Cáceres JF
    Nucleic Acids Res; 2000 Dec; 28(24):4822-31. PubMed ID: 11121472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An intron enhancer recognized by splicing factors activates polyadenylation.
    Lou H; Gagel RF; Berget SM
    Genes Dev; 1996 Jan; 10(2):208-19. PubMed ID: 8566754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SF2 and SRp55 regulation of CD45 exon 4 skipping during T cell activation.
    Lemaire R; Winne A; Sarkissian M; Lafyatis R
    Eur J Immunol; 1999 Mar; 29(3):823-37. PubMed ID: 10092085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. XE7: a novel splicing factor that interacts with ASF/SF2 and ZNF265.
    Mangs AH; Speirs HJ; Goy C; Adams DJ; Markus MA; Morris BJ
    Nucleic Acids Res; 2006; 34(17):4976-86. PubMed ID: 16982639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional analysis of pre-mRNA splicing factor SF2/ASF structural domains.
    Cáceres JF; Krainer AR
    EMBO J; 1993 Dec; 12(12):4715-26. PubMed ID: 8223480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.